Department of General Surgery, Fuyang Hospital Affiliated to Anhui Medical University, Fuyang, P.R. China.
School of Nursing, Anhui Medical University, HeFei, P.R. China.
Bioengineered. 2021 Dec;12(2):12246-12262. doi: 10.1080/21655979.2021.2006552.
This study aimed to investigate the distribution laws and research frontiers of international literature, so as to present a holistic bibliometric evaluation of the studies on breast cancer liver metastasis(BCLM). Data were collected from the Web of Science Core Collection database, including publications, year, country, journal, author and keywords. The software VOSviewer and CiteSpace were used for bibliometric coupling, co-authorship, co-citation and co-occurrence analysis. In total, 1,031 publications were analyzed from 2004 to 2020 on BCLM. The year with the highest number of publications was 2006, with 103 papers. The United States, followed by China and Germany were the leading countries on BCLM, accounting for 59% of the whole. The journals that published about BCLM were mainly located in Q1/Q2. Keywords co-occurrence analysis divides BCLM into five clusters:'basic research', 'auxiliary diagnosis and therapy', 'liver resection', 'clinical trial' and 'prognosis'. Main treatment therapies were the latest focus. Burst detection indicated that the trends in BCLM concentrated on subtype and SEER. There is apparently brighter perspective for BCLM research in the coming years, especially in liver resection, subtype and bioinformatics. The consequence of our study as the exclusive scientific evaluation offered an integral overview of BCLM, particularly for research focus and future directions, which can further accurately guide scholars on diagnosis, treatment, and personalized prevention.
本研究旨在探究国际文献的分布规律和研究前沿,从而对乳腺癌肝转移(BCLM)的研究进行全面的文献计量评估。数据来源于 Web of Science 核心合集数据库,包括出版物、年份、国家、期刊、作者和关键词。使用 VOSviewer 和 CiteSpace 软件进行文献计量耦联、合著、共引和共词分析。共分析了 2004 年至 2020 年关于 BCLM 的 1031 篇出版物。发文量最高的年份是 2006 年,有 103 篇论文。美国、中国和德国是 BCLM 的主要国家,占总数的 59%。发表关于 BCLM 的期刊主要位于 Q1/Q2。关键词共现分析将 BCLM 分为五个聚类:“基础研究”、“辅助诊断和治疗”、“肝切除术”、“临床试验”和“预后”。主要治疗方法是最新的研究重点。突发检测表明,BCLM 的趋势集中在亚型和 SEER 上。未来几年 BCLM 的研究显然有更光明的前景,特别是在肝切除术、亚型和生物信息学方面。我们的研究结果作为独家科学评估,提供了 BCLM 的全面概述,特别是对研究重点和未来方向的评估,这可以进一步为学者提供更准确的诊断、治疗和个性化预防指导。
J Cardiothorac Surg. 2024-5-11
J Control Release. 2022-5
J Cancer Res Clin Oncol. 2024-6-24
Front Immunol. 2022
Front Med (Lausanne). 2022-8-3
Front Immunol. 2023
Front Biosci (Landmark Ed). 2022-8-31
Ann Med Surg (Lond). 2024-10-18
Int Urol Nephrol. 2025-5
Front Oncol. 2024-10-25
Medicine (Baltimore). 2024-9-27
BMC Bioinformatics. 2020-12-3
Front Oncol. 2020-9-2